Genmab A/S (LON:0MGB)
London
· Delayed Price · Currency is GBP · Price in DKK 1,286.75
-7.20 (-0.56%)
At close: Apr 16, 2025
Genmab Employees
Genmab had 2,682 employees as of December 31, 2024. The number of employees increased by 478 or 21.69% compared to the previous year.
Employees
2,682
Change (1Y)
478
Growth (1Y)
21.69%
Revenue / Employee
889.99K GBP
Profits / Employee
324.31K GBP
Market Cap
9.55B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| HSBC Holdings | 211,304 |
| Shell | 96,000 |
| Unilever | 115,964 |
| Rio Tinto Group | 60,000 |
| RELX PLC | 36,400 |
| British American Tobacco p.l.c. | 48,989 |
| Rolls-Royce Holdings | 42,400 |
Genmab News
- 9 days ago - Genmab's Outlook Beyond Darzalex's Patent Cliff - Seeking Alpha
- 9 days ago - Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2025 - GlobeNewsWire
- 10 days ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 14 days ago - Genmab A/S Share Capital Reduction - GlobeNewsWire
- 17 days ago - Transactions In Connection with Share Buy-back Program - GlobeNewsWire
- 23 days ago - Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons - GlobeNewsWire
- 23 days ago - Genmab drops as Bernstein cuts on Darzalex patent cliff - Seeking Alpha
- 24 days ago - TIVDAK® (tisotumab vedotin) Approved by European Commission for Previously Treated Recurrent or Metastatic Cervical Cancer - GlobeNewsWire